Month: July 2024

  • What Is The Forecast Growth Rate For The Personal Health Record Software Market?

    What Is The Forecast Growth Rate For The Personal Health Record Software Market?

    The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

    Market Overview:

    • 2023 to 2024 Growth:
      • Market size: $9.20 billion in 2023 to $10.14 billion in 2024.
      • CAGR: 10.3%.
    • Historic Growth Drivers:
      • Market demand and supply dynamics.
      • Government initiatives.
      • Integration with traditional record-keeping.
      • Increased chronic disease management.
      • Consumer demand for accessible healthcare information.

    Future Projections and Trends

    2024 to 2028 Forecast:

    • Expected Growth:
      • Market size: $10.14 billion in 2024 to $14.64 billion in 2028.
      • CAGR: 9.6%.
    • Growth Drivers:
      • Centralizing and streamlining healthcare information.
      • Rising initiatives promoting patient-centric care.
      • Increasing consumer awareness and adoption.
    • Major Trends:
      • Government initiatives for patient-centric care.
      • Growing demand for centralized healthcare information.
      • Rising patient awareness about medical information management.

    Read More On The Personal Health Record Software Market Report 2024 – https://www.thebusinessresearchcompany.com/report/personal-health-record-software-global-market-report

    Digital Health Solutions Fueling Market Growth

    Integration of Digital Health:

    • Impact on Market:
      • Empowers patients and improves care coordination.
      • Enhances clinical decision-making and health outcomes.
    • Key Statistics:
      • Australian Digital Health Agency (2022): 118.2 million telehealth services provided to 18 million patients.
      • Rock Health Survey (2023): 80% of U.S. adults accessed care remotely, up from 72% in 2021.

    Key Players in the Market

    Major Companies:

    • GE Healthcare
    • Cerner Corporation
    • Allscripts
    • eClinicalWorks
    • Athenahealth
    • NextGen Healthcare
    • Meditech
    • Greenway Health
    • CareCloud Inc.
    • Kareo
    • Zapbuild
    • E-MDs Inc.
    • SoftClinic Software
    • Practice Fusion Inc.
    • ChARM Health

    AI Integration Transforming the Market

    Advancements in AI:

    • Key Developments:
      • Amazon Web Services (AWS) launched AWS HealthScribe in July 2023.
      • Uses generative AI to create clinical documentation from patient-clinician conversations.
      • Enhances consultation efficiency and boosts medical scribe workflow.
    • Benefits of AI Integration:
      • Accelerates clinical documentation.
      • Improves consultation efficiency.
      • Helps healthcare software vendors build advanced clinical applications.

    Thoma Bravo’s Strategic Acquisition of NextGen Healthcare

    Significant Acquisition:

    • Details:
      • Thoma Bravo acquired NextGen Healthcare in November 2023 for $1.8 billion.
    • Expected Benefits:
      • Leverage Thoma Bravo’s expertise to accelerate NextGen’s leadership in healthcare solutions.
      • Focus on long-term growth and operational excellence.

    Market Segmentation and Regional Insights

    Market Segmentation:

    • By Component:
      • Software and Mobile Applications
      • Service
    • By Deployment:
      • Cloud-Based
      • Web-Based
    • By Architecture:
      • Payer-Tethered
      • Provider-Tethered
      • Standalone

    Regional Insights:

    • 2023 Leading Region:
      • North America was the largest region in the personal health record software market.

    The personal health record software market is set for significant growth, driven by technological advancements, increasing consumer demand, and strategic initiatives by key players and government bodies. The integration of AI and digital health solutions will further revolutionize the market, making healthcare more accessible, efficient, and patient-centric.

    Request for A Sample Of The Global Personal Health Record Software Market Report:
    https://www.thebusinessresearchcompany.com/sample_request?id=13910&type=smp

  • Periodontal Market Growth Analysis Till 2033 By The Business Research Company

    Periodontal Market Growth Analysis Till 2033 By The Business Research Company

    The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

    Market Overview:

    • 2023 to 2024 Growth:
      • Market size: $10.55 billion in 2023 to $11.78 billion in 2024.
      • CAGR: 11.6%.
    • Historic Growth Drivers:
      • Awareness campaigns and education.
      • Aging population.
      • Rise in disposable income.
      • Increased incidence of diabetes.
      • Changing lifestyles.

    Read More On The Periodontal Market Report 2024 – https://www.thebusinessresearchcompany.com/report/periodontal-global-market-report

    Future Projections and Trends

    2024 to 2028 Forecast:

    • Expected Growth:
      • Market size: $11.78 billion in 2024 to $17.90 billion in 2028.
      • CAGR: 11.0%.
    • Growth Drivers:
      • Personalized medicine approaches.
      • Telehealth and remote monitoring.
      • Increasing focus on preventive dentistry.
      • Digital treatment planning platforms.
      • Patient-centric care models.
    • Major Trends:
      • Shift towards minimally invasive procedures.
      • Integration of 3D printing in dentistry.
      • Focus on patient education and engagement.
      • Evolving periodontal biomarkers.
      • Holistic approaches to oral health.

    Surge in Dental Tourism Fuels Growth

    Impact of Dental Tourism:

    • Definition and Benefits:
      • Dental tourism involves traveling to other countries for dental care.
      • Offers cost-effective alternatives for quality dental care.
    • Key Statistics:
      • Lara Smile (2022): Dental tourism grew 15% globally.
      • Turkey: Dental tourists increased from 135,000 in 2021 to 200,000 in 2022.

    Key Players in the Periodontal Market

    Major Companies:

    • Novartis AG
    • 3M Company
    • Medtronic PLC
    • Danaher Corporation
    • Micron Corporation Inc.
    • Colgate-Palmolive Company
    • Henry Schein Inc.
    • Bausch Health Companies Inc.
    • Zimmer Biomet Inc.
    • STERIS plc
    • Dentsply Sirona Inc.
    • Straumann AG

    Innovative Educational Apps in Oral Health Services

    Development of Educational Apps:

    • Key Initiative:
      • OraPharma Inc. launched MyPerioHealth App in October 2021.
    • Features:
      • Interactive oral health educational tool.
      • Allows patients and dental professionals to understand periodontal disease stages and grades.
      • Designed to be used with American Academy of Periodontology (AAP) guidelines.

    KC Biotech and Oral Biolife Partnership

    Groundbreaking Partnership:

    • Details:
      • KC Biotech Inc. partnered with Oral Biolife in November 2023.
    • Objective:
      • Address periodontitis in companion animals.
      • Combine Oral Biolife’s PiezoGEL(TM) with Likarda’s hydrogel delivery systems.
    • Benefits:
      • Revolutionary treatment for periodontal disease.
      • Impact on long-term disease and productivity loss.

    Market Segmentation and Regional Insights

    Market Segmentation:

    • By Product:
      • Diagnostic Instruments
      • Treatment Instruments
      • Surgical Instruments
    • By Procedures:
      • Scaling and Root Planing
      • Gum Grafting
      • Regenerative Therapy
      • Dental Crown Lengthening
      • Periodontal Pocket Procedures
      • Single Tooth Dental Implants
      • Multiple Tooth Dental Implants
    • By End User:
      • Hospitals
      • Dental Clinics
      • Group Dental Practice
      • Ambulatory Surgical Centers

    Regional Insights:

    • 2023 Leading Region:
      • North America was the largest region in the periodontal market.
    • Fastest-Growing Region:
      • Asia-Pacific is expected to be the fastest-growing region during the forecast period.

    The periodontal market is on a path of rapid growth, driven by advancements in personalized medicine, telehealth, and preventive dentistry. The rise of dental tourism and innovative educational apps are key factors fueling this growth. With significant contributions from major players and groundbreaking partnerships, the market is poised to see substantial advancements in the coming years.

    Request for A Sample Of The Global Periodontal Market Report:
    https://www.thebusinessresearchcompany.com/sample_request?id=13907&type=smp

  • Key Insights On The Patient Flow Management Solutions Market 2024 – Size, Driver, And Major Players

    Key Insights On The Patient Flow Management Solutions Market 2024 – Size, Driver, And Major Players

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    As per The Business Research Company’s Patient Flow Management Solutions Global Market Report 2024, the patient flow management solutions market is expected to show significant growth in the forecast period.

    Market Overview

    • 2023 to 2024 Growth:
      • Market size: $1.33 billion in 2023 to $1.65 billion in 2024.
      • CAGR: 24.2%.
    • Historic Growth Drivers:
      • Increasing demand for healthcare services.
      • Regulatory mandates and compliance requirements.
      • Rising healthcare costs.
      • Need for operational efficiency.

    Future Projections and Trends

    2024 to 2028 Forecast:

    • Expected Growth:
      • Market size: $1.65 billion in 2024 to $3.84 billion in 2028.
      • CAGR: 23.5%.
    • Growth Drivers:
      • Adoption of artificial intelligence and machine learning.
      • Integration of telemedicine and remote monitoring solutions.
      • Growing focus on patient-centered care models.
      • Expansion of healthcare infrastructure in emerging markets.
      • Emphasis on data interoperability and analytics.
    • Major Trends:
      • Shift towards value-based care.
      • Emphasis on patient engagement and experience.
      • Rise of predictive analytics for demand forecasting.
      • Utilization of mobile health (mHealth) applications.
      • Emergence of cloud-based patient flow management solutions.

    View More On The Patient Flow Management Solutions Market Report 2024 – https://www.thebusinessresearchcompany.com/report/patient-flow-management-solutions-global-market-report

    Impact of Rising Hospital Admissions on Growth

    Effect of Increased Hospital Admissions:

    • Definition and Benefits:
      • Hospital admission involves entering a hospital for medical care.
      • Patient flow management solutions assist in appointment scheduling and real-time patient tracking.
      • Benefits include reduced wait times, improved patient satisfaction, and efficient use of resources.
    • Key Statistics:
      • National Health Service (2023): Hospital admissions due to smoking increased from 389,800 in 2021–22 to 408,700 in 2022–23, a 4.8% rise.

    Key Players in the Patient Flow Management Solutions Market

    Major Companies:

    • McKesson Corporation
    • Stanley Black & Decker Inc.
    • Cerner Corporation
    • Epic Systems Corporation
    • Hospira
    • Hill-Rom Holdings Inc.
    • Getinge AB
    • Allscripts Healthcare Solutions Inc.
    • Aptean Inc.
    • Ascom Holding AG
    • Care Logistics LLC

    Innovative Solutions in Patient Flow Management

    Focus on Healthcare Data Capabilities:

    • Development of Healthcare Data Capabilities:
      • Collect, store, analyze, and visualize health data.
    • Key Initiative:
      • Google Cloud launched three Healthcare Data Engine (HDE) accelerators in November 2022.
      • Aim to improve patient flow, connect patients to community resources, and leverage social determinants of health (SDOH) datasets.
      • Enhance facility efficiency metrics to manage patient admissions, transfers, and length of stay.

    LeanTaaS Enhances Healthcare Capacity Solutions

    Strategic Acquisition:

    • Details:
      • LeanTaaS Inc. acquired Hospital IQ in January 2022.
    • Objective:
      • Address capacity management and staffing shortages.
      • Improve patient access, staff satisfaction, and revenue.
    • Capabilities:
      • Hospital IQ provides patient flow, scheduling, and capacity management solutions.

    Market Segmentation and Regional Insights

    Market Segmentation:

    • By Component:
      • Hardware
      • Software
      • Services
    • By Type:
      • Event-Driven Patient Tracking
      • Real-Time Locating Systems
    • By Product:
      • Integrated
      • Standalone
    • By Delivery Mode:
      • Web-Based
      • On-Premise
      • Cloud-Based
    • By End User:
      • Hospitals
      • Clinics
      • Other End Users

    Regional Insights:

    • 2023 Leading Region:
      • North America was the largest region in the patient flow management solutions market.

    The patient flow management solutions market is experiencing exponential growth, driven by advancements in AI, telemedicine integration, and a focus on patient-centered care. Rising hospital admissions and innovative healthcare data capabilities are further propelling this growth. With significant contributions from major players and strategic acquisitions, the market is poised for substantial advancements in the coming years.

    Request A Sample Of The Global Patient Flow Management Solutions Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=13902&type=smp

  • 5 Key Insights On The Smart Contact Lenses Market 2024

    5 Key Insights On The Smart Contact Lenses Market 2024

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    As per The Business Research Company’s Smart Contact Lenses Global Market Report 2024, the smart contact lenses market is expected to show significant growth in the forecast period.

    The smart contact lenses market has seen significant growth in recent years. It grew from $5.14 billion in 2023 to $5.80 billion in 2024 at a compound annual growth rate (CAGR) of 12.8%.

    Key Drivers of Recent Growth

    • Prevalence of Vision-Related Disorders: Increasing cases of vision-related disorders and eye conditions.
    • Demand for Real-Time Health Monitoring: Rising interest in real-time health monitoring and diagnostics.
    • Awareness and Applications: Growing awareness about the benefits of smart contact lenses and their expanding applications in healthcare and medical diagnostics.
    • R&D Activities: Surge in research and development activities.

    Future Market Outlook

    The smart contact lenses market size is expected to grow rapidly, reaching $8.92 billion by 2028, with a CAGR of 11.3%.

    Drivers of Future Growth

    • Personalized Healthcare: Growing demand for personalized healthcare solutions.
    • Aging Population: Increase in age-related eye disorders due to an aging population.
    • Wearable Devices: Rising adoption of wearable devices for health and lifestyle management.
    • Non-Invasive Monitoring: Increased interest in non-invasive health monitoring solutions.
    • Emerging Markets: Untapped potential in developing regions.

    View More On The Smart Contact Lenses Market Report 2024 – https://www.thebusinessresearchcompany.com/report/smart-contact-lenses-global-market-report

    Major Trends

    • AR and VR Integration: Integration of augmented reality (AR) and virtual reality (VR) technologies.
    • Technological Advancements: Progress in microelectronics and miniaturization.
    • Continuous Innovation: Ongoing innovation in smart contact lens technology.
    • Enhanced Connectivity: Improved connectivity features and IoT integration.

    Glaucoma Management with Smart Contact Lenses

    The increasing prevalence of glaucoma is expected to drive the growth of the smart contact lenses market.

    • Glaucoma Prevalence: Around 80 million individuals currently have glaucoma globally, expected to increase to over 111 million by 2040.
    • Disease Management: Smart contact lenses help monitor intraocular pressure, providing continuous data for better disease management and early intervention.

    Leading Companies in the Market

    Several major companies are operating in the smart contact lenses market:

    • Google LLC
    • Johnson & Johnson
    • Huawei Technologies Co., Ltd.
    • Hitachi Ltd.
    • Sony Group Corporation
    • International Business Machines Corporation
    • Samsung Electronics Co Ltd
    • Novartis AG
    • Liner Technologies Inc.
    • STMicroelectronics N.V.
    • Alcon Vision LLC
    • Tissot Medical Research SA

    Advancements in Augmented Reality Contact Lenses

    Companies are developing advanced technologies like augmented reality (AR) contact lenses.

    • Mojo Vision: Developed Mojo Lens, incorporating micro-LED display technology with enhanced display, communication, eye tracking functionality, and power system.

    Meta Platforms Inc. and Luxexcel Holding B.V.

    Meta Platforms Inc. acquired Luxexcel Holding BV in December 2022.

    • Acquisition Purpose: To strengthen partnership and progress towards the development of AR glasses.
    • Luxexcel: A Netherlands-based manufacturer of smart contact lenses.

    Market Segmentation

    The smart contact lenses market is segmented into:

    1. By Type:
      • Daily Wear Soft Lenses
      • Extended-Wear
      • Planned Replacement
      • Rapid Gas Permeable (RGP)
      • Other Types
    2. By Application:
      • Intraocular Pressure Monitoring
      • Continuous Glucose Monitoring
    3. By End User:
      • Hospitals
      • Ophthalmology Clinics
      • Other End Users

    Regional Insights

    • Largest Market: North America was the largest region in the smart contact lenses market in 2023.
    • Fastest-Growing Market: Asia-Pacific is expected to be the fastest-growing region in the forecast period.

    The smart contact lenses market is poised for significant growth and innovation, driven by advancements in technology and increasing demand for personalized and non-invasive healthcare solutions.

    Request A Sample Of The Global Smart Contact Lenses Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=13932&type=smp

  • Future Growth Forecast For The Self-Administered Parenteral Global Market 2024-2033

    Future Growth Forecast For The Self-Administered Parenteral Global Market 2024-2033

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

    The self-administered parenteral market is experiencing robust growth, expanding from $23.14 billion in 2023 to $24.57 billion in 2024, at a compound annual growth rate (CAGR) of 6.1%.

    • Market Growth: $23.14 billion in 2023 to $24.57 billion in 2024
    • CAGR: 6.1%

    Historical Growth Drivers

    Several factors have contributed to the market’s growth in recent years.

    • Chronic Diseases: Increasing prevalence of chronic conditions
    • Aging Population: Rising number of elderly individuals
    • Government Initiatives: Policies to promote patient self-management
    • Patient Education: Programs to educate and support patients
    • Bone Disorders: Higher incidences of related health issues

    Future Market Projections

    The self-administered parenteral market is poised for steady growth, projected to reach $29.8 billion by 2028, at a CAGR of 4.9%.

    • Market Projection: $29.8 billion by 2028
    • CAGR: 4.9%

    View More On The Self-Administered Parenteral Market Report 2024 – https://www.thebusinessresearchcompany.com/report/self-administered-parenteral-global-market-report

    Forecasted Growth Drivers

    Key factors expected to drive future market growth include:

    • Home Healthcare: Increasing preference for home-based care
    • Telemedicine: Growth of remote patient monitoring
    • Patient Initiatives: Continued education and support
    • Personalized Medicine: Expansion of tailored treatments

    Major Trends in the Market

    Several significant trends are expected to shape the market landscape.

    • Digital Health Solutions: Integration of advanced technologies
    • Customized Drug Delivery: Development of tailored delivery systems
    • Targeted Therapies: Emergence of precise treatment options
    • Biologics Advancements: Innovations in biological medications

    Chronic Diseases Fuel Market Expansion

    The prevalence of chronic diseases significantly contributes to market growth.

    • Disease Management: Self-administered parenterals improve adherence
    • Population Statistics: Expected increase in chronic disease cases among those aged 50 and above
      • 5% increase in chronic disease cases from 2020 to 2050

    Key Market Players

    Several major companies are prominent in the self-administered parenteral market.

    • Leading Companies: Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., and AstraZeneca PLC

    Innovative Autoinjector Solutions

    Companies are focusing on innovative products to enhance patient treatment.

    • Example Product: UDENYCA autoinjector by Coherus BioSciences Inc.
      • Features: Intuitive design, fast dosing, at-home and in-office use

    Halozyme Therapeutics’ Strategic Acquisition

    Halozyme Therapeutics Inc. acquired Antares Pharma Inc. to strengthen its market position.

    • Acquisition Value: $960 million
    • Objective: Expand platform technologies and capabilities

    Market Segmentation

    The self-administered parenteral market is segmented into several categories.

    • By Product: Pre-Filled Syringes, Autoinjectors, Pen Injectors, Other Products
    • By Usage: Disposable, Reusable
    • By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Home Healthcare Providers, Specialty Clinics, Other Channels
    • By Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, Other Applications

    Regional Insights

    North America was the largest region in the self-administered parenteral market in 2023.

    • Leading Region: North America

    Conclusion

    The self-administered parenteral market is on a growth trajectory, driven by increasing chronic diseases, technological advancements, and strategic acquisitions. With ongoing innovations and rising patient preference for home healthcare, the market is set to continue its expansion in the coming years.

    Request A Sample Of The Global Self-Administered Parenteral Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=13927&type=smp

  • How Is The Sarcopenia Treatment Market Expected To Grow Through 2024-2033

    How Is The Sarcopenia Treatment Market Expected To Grow Through 2024-2033

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    According to The Business Research Company’s Sarcopenia Treatment Global Market Report 2024, the sarcopenia treatment market is expected to show promising growth in the forecast period.

    Market Overview

    • Strong Growth: The sarcopenia treatment market has shown significant growth, increasing from $3.30 billion in 2023 to $3.52 billion in 2024 at a CAGR of 6.6%.
    • Future Projections: Expected to reach $4.44 billion by 2028, growing at a CAGR of 6.0%.

    Factors Driving Growth

    • Aging Population: An increase in the elderly population leads to a higher prevalence of sarcopenia.
    • Awareness and Diagnosis: Improved recognition and diagnosis of the condition have contributed to market growth.
    • Lifestyle Changes: Sedentary lifestyles and poor dietary habits increase the risk of sarcopenia.
    • Public Health Initiatives: Government and healthcare organizations are actively promoting interventions to manage sarcopenia.
    • Regulatory Approvals: Approval of new treatments and therapies boosts market expansion.

    Future Growth Drivers

    • Personalized Medicine: Tailored treatment plans improve patient outcomes.
    • Nutritional Interventions: Enhanced focus on diet and supplements to combat sarcopenia.
    • Digital Health Platforms: Integration of technology for better patient management.
    • Patient Education and Empowerment: Increased awareness and self-management strategies.
    • Global Health Initiatives: International efforts to address sarcopenia and related health issues.

    View More On The Sarcopenia Treatment Market Report 2024 – https://www.thebusinessresearchcompany.com/report/sarcopenia-treatment-global-market-report

    Emerging Trends

    • Personalized Therapies: Customized treatment options are becoming more prevalent.
    • Novel Drug Classes: Development of new medications specifically targeting sarcopenia.
    • Digital Health Integration: Use of apps and wearables to monitor and manage the condition.
    • Collaborative Research Initiatives: Joint efforts between companies and research institutions.
    • Research and Development: Continuous innovation in treatment methods.

    Impact of Malnutrition

    • Global Challenge: Malnutrition, including both undernutrition and obesity, exacerbates sarcopenia.
    • WHO Report: As of 2022, malnutrition affects millions globally, highlighting the need for effective sarcopenia treatments.
    • Interventions: Nutritional therapy and exercise are key in improving muscle mass and strength.

    Key Players

    • Major Companies: Pfizer Inc., F-Hoffmann La-Roche, Merck Sharp & Dohme Corp., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Abbott Laboratories Inc., GlaxoSmithKline plc, Eli Lilly and Company.
    • Others: BASF SE, Nestle Health Science, Haleon Group, Regeneron Pharmaceuticals Inc., DSM, Amway, Perrigo Company PLC, Intas Pharmaceuticals Ltd, Zydus Lifesciences, Fermenta Biotech Limited, Metagenics LLC, Ion Labs Inc., Makers Nutrition LLC, NutraScience Labs, AstaReal AB, NutraPak USA, BioThrive Sciences, Wellona Pharma, Healing Pharma India Pvt. Ltd., Nutrafill.

    Notable Developments

    • Biophytis FDA Authorization: In September 2023, Biophytis received FDA approval for the SARA-31 Phase 3 study to evaluate Sarconeos (BIO101) in sarcopenia treatment.
      • Study Details: Involves around 900 patients aged over 65, focusing on mobility disability, walking speed, hand grip strength, and quality of life.

    Strategic Acquisitions

    • Rejuveron Life Sciences AG: Acquired Rejuvenate Biomed NV for $16.99 million in October 2021 to accelerate clinical progress in sarcopenia therapeutics.
      • Focus: Development of RJx-01 for both acute and chronic sarcopenia.

    Market Segmentation

    • By Treatment Type: Protein supplements, Vitamin B12 supplements, Vitamin D and Calcium supplements, other treatments.
    • By Type: Primary sarcopenia, secondary sarcopenia.
    • By Route of Administration: Oral, parenteral, enteral.
    • By Distribution Channel: Hospital pharmacies, retail pharmacies, online pharmacies, other channels.

    Regional Insights

    • North America: The largest market in 2023.
    • Asia-Pacific: Expected to be the fastest-growing region in the forecast period.

    Conclusion

    The sarcopenia treatment market is poised for robust growth, driven by an aging population, increasing awareness, and innovative treatment approaches. With significant advancements and strategic initiatives by key players, the market is set to expand further, offering improved outcomes for those affected by sarcopenia.

    Request A Sample Of The Global Sarcopenia Treatment Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=13926&type=smp

  • Overview Of The Sanger Sequencing Market 2024-2033: Growth And Major Players Analysis

    Overview Of The Sanger Sequencing Market 2024-2033: Growth And Major Players Analysis

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    Market Size and Growth

    • 2023 Growth: The Sanger sequencing market reached $2.29 billion in 2023.
    • 2024 Projection: It is expected to grow to $2.75 billion in 2024, reflecting a compound annual growth rate (CAGR) of 19.9%.
    • 2028 Projection: By 2028, the market is projected to reach $5.30 billion, with a CAGR of 17.8%.

    Drivers of Historic Growth

    • Increased Research Demand: Growing research activities have fueled market expansion.
    • Medical Diagnostics: Rising use in medical diagnostics has boosted market size.
    • Pharmaceutical Development: Enhanced pharmaceutical development activities have contributed to growth.
    • Agricultural Applications: Expanded use in agriculture for crop improvement and disease resistance.
    • Forensic Analysis: Increasing forensic analysis needs.
    • Biomarker Discovery: Growing importance of biomarkers in personalized medicine.
    • Genetic Evolution Studies: Increasing studies on genetic evolution.

    View More On The Sanger Sequencing Market Report 2024 – https://www.thebusinessresearchcompany.com/report/sanger-sequencing-global-market-report

    Drivers of Future Growth

    • Clinical Genomics Integration: Enhanced integration in clinical genomics.
    • Agricultural Genomics Expansion: Broader applications in agricultural genomics.
    • Drug Safety and Pharmacogenomics: Rising importance in drug safety and pharmacogenomics.
    • Prenatal and Newborn Screening: Increasing use in prenatal and newborn screening.
    • Environmental DNA Analysis: Expanding applications in environmental DNA analysis.

    Major Market Trends

    • Technological Advancements: Continuous technological advancements in sequencing technology.
    • Next-Generation Sequencing Demand: Growing demand for next-generation sequencing.
    • Clinical Diagnostics Applications: Increased use in clinical diagnostics.
    • Genomics Research Investments: Rising investments in genomics research.
    • Personalized Medicine: Expanding use in personalized medicine.

    Impact of Genetic Illness Surge

    • Genetic Illnesses: Rise in genetic illnesses propels market growth.
    • Diagnostics: Sanger sequencing used for diagnosing genetic disorders.
    • Rare Diseases: Over 7,000 known rare genetic diseases, affecting 30 million people in the US.

    Key Companies in the Market

    • Hoffmann-La Roche
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Eurofins Scientific
    • Illumina Inc.
    • Beckman Coulter
    • PerkinElmer Inc.
    • BGI Group
    • LGC Limited
    • GenScript
    • Oxford Nanopore Technologies
    • Pacific Biosciences of California Inc.
    • Macrogen Inc.
    • GENEWIZ Inc.

    Advancements in Sanger Sequencing Technology

    • Promega Corporation: Launched the ProDye Terminator Sequencing System in October 2021.
    • System Features: Compatible with all capillary electrophoresis (CE) platforms, enhancing laboratory capabilities.
    • Technological Edge: Uses proprietary thermostable DNA polymerase for high efficiency.

    Strategic Acquisitions

    • QIAGEN and Verogen: In January 2023, QIAGEN acquired Verogen for $150 million.
    • Forensic Science: Strengthened leadership in forensic science.
    • Market Reach: Enhanced market-leading sample extraction and library prep automation capabilities.

    Market Segmentation

    • By Sequencing: Shotgun Sequencing, Targeted Gene Sequencing, Other Sequencing.
    • By Laboratory: Wet Labs, Dry Labs.
    • By Research: In-House, Outsourced.
    • By Application: Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized Medicine, Forensics, Other Applications.
    • By End User: Academic, Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals, Clinics.

    Regional Insights

    • North America: Largest region in the Sanger sequencing market in 2023.

    The Sanger sequencing market is poised for significant growth, driven by technological advancements, expanding applications, and strategic acquisitions. With a strong presence in research, diagnostics, and personalized medicine, the market is set to transform various sectors, underscoring its critical role in advancing genomic science.

    Request A Sample Of The Global Sanger Sequencing Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=13925&type=smp

  • Comprehensive Analysis On Size, Share, And Drivers Of The Operating Room Integration Market

    Comprehensive Analysis On Size, Share, And Drivers Of The Operating Room Integration Market

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

    Overview of Market Growth

    • The operating room integration market size has grown rapidly in recent years.
      • Growth from $1.93 billion in 2023 to $2.18 billion in 2024 at a CAGR of 13.1%.
      • Factors driving growth: healthcare infrastructure development, shift towards minimally invasive surgical techniques, increasing complexity of surgical procedures.

    Future Market Projections

    • The market is expected to see rapid growth in the next few years.
      • Projected growth to $3.35 billion in 2028 at a CAGR of 11.3%.
      • Key drivers: integration of robotic-assisted surgery and AI, adoption of telemedicine and remote healthcare solutions, increased focus on infection control and patient safety, emphasis on data-driven decision-making in healthcare.

    Major Trends Shaping the Market

    • Advancements in medical imaging technologies.
    • Development of digital imaging systems.
    • Minimally invasive surgery techniques.
    • Improved diagnostic tools.

    View More On The Operating Room Integration Market Report 2024 – https://www.thebusinessresearchcompany.com/report/operating-room-integration-global-market-report

    Surgical Procedure Surge Propels Market Growth

    • Increasing number of surgical procedures drives market growth.
      • Surgical procedures are essential for treating various diseases and disorders through invasive methods.
      • Operating room integration enhances precision and safety, improving surgical outcomes.
      • Example: In 2022, plastic surgeons performed approximately 14.9 million surgical and 18.8 million non-surgical procedures globally, an 11.2% rise in total procedures (ISAPS).

    Key Market Players

    • Major companies in the market:
      • Johnson & Johnson
      • Sony Electronics Inc.
      • Siemens Healthineers
      • Fujifilm Holdings Corporation
      • Stryker Corporation
      • GE Healthcare
      • Zimmer Biomet Holdings Inc.
      • Olympus Corporation
      • Smith & Nephew plc
      • Steris Corporation
      • Merivaara Corporation
      • Optovue Inc.
      • IntegriTech

    Advanced Visualization and Integration Solutions

    • Focus on advanced technological solutions to gain a competitive edge.
      • Visualization and integration solutions provide a unified view of diverse data, aiding decision-making.
      • Example: In July 2023, Olympus Corporation launched the EasySuite ES-IP system, a modular, scalable, workflow-based visualization and integration solution for operating rooms.

    Significant Acquisition in the Market

    • Stryker Corporation’s acquisition of Vocera Communications.
      • In February 2022, Stryker acquired Vocera Communications for $3 billion.
      • The acquisition enhances Stryker’s digital healthcare offerings, including operating room integration and digital care coordination.

    Market Segmentation

    • By Component: Software, Services.
    • By Device Type: Audio Video Management System, Display System.
    • By Application: General Surgery, Orthopedic Surgery, Cardiovascular Surgery, Neurosurgery.
    • By End-use: Hospitals, Ambulatory Surgical Centers.

    Regional Insights

    • North America was the largest region in the operating room integration market in 2023.
    • Asia-Pacific is expected to be the fastest-growing region in the forecast period.

    The operating room integration market is poised for significant growth, driven by technological advancements, increasing surgical procedures, and strategic acquisitions. As healthcare continues to evolve, the integration of advanced systems and solutions will play a critical role in enhancing patient care and operational efficiency.

    Request A Sample Of The Global Operating Room Integration Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=13893&type=smp

  • Global Offsite Sterilization Service Market Key Insights 2024-2033

    Global Offsite Sterilization Service Market Key Insights 2024-2033

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    According to The Business Research Company’s Offsite Sterilization Service Global Market Report 2024, the offsite sterilization service market is expected to show promising growth in the forecast period.

    Market Growth Overview

    • The offsite sterilization service market has seen robust growth in recent years.
      • Market size increased from $2.22 billion in 2023 to $2.39 billion in 2024.
      • Achieved a compound annual growth rate (CAGR) of 7.6%.
      • Key drivers: economic growth, industrialization, changing consumer preferences, regulatory changes, technological advancements, globalization, and supply chain dynamics.

    Future Market Projections

    • The market is expected to continue its strong growth trajectory.
      • Projected to reach $3.06 billion in 2028 at a CAGR of 6.4%.
      • Growth drivers: sustainability initiatives, e-commerce growth, urbanization, health and safety concerns, customization, and personalization.

    Major Trends in the Forecast Period

    • Increasing demand for mobile sterilization units.
    • Adoption of sustainable sterilization practices.
    • Expansion of sterilization services in emerging markets.
    • Integration of robotics and automation.
    • Focus on sterilization services for pharmaceuticals and biotechnology industries.

    View More On The Offsite Sterilization Service Market Report 2024 – https://www.thebusinessresearchcompany.com/report/offsite-sterilization-service-global-market-report

    HAIs Driving Demand for Effective Offsite Sterilization Services

    • Hospital-acquired infections (HAIs) are propelling the growth of offsite sterilization services.
      • HAIs are infections acquired during healthcare treatment in hospitals or other facilities.
      • Offsite sterilization services implement measures to minimize infection risks and enhance patient safety.
      • Example: In Australia, hospitals recorded 1,546 Staphylococcus aureus bloodstream infections (SABSI) over 21.1 million patient care days in 2021-22.

    Key Market Players

    • Major companies in the market include:
      • Schneider Electric SE
      • Stryker Corporation
      • Terumo BCT Corporation
      • Steris plc
      • Andersen Scientific Inc.
      • Sotera Health Company
      • Sterigenics LLC
      • Cantel Medical Corporation
      • Wipak Holding GmbH
      • Koch Industries Inc.
      • CRETEX Medical
      • Noxilizer Inc.
      • Blue Line Sterilization Services LLC

    Enhancing Efficiency in Hospital Settings with Latest Sterilization Technology

    • Companies are developing innovative facilities to improve efficiency and profitability.
      • Example: Innovative Sterilization Technologies LLC launched ONE TRAY Total Solution for its new offsite sterilization facility.
      • This system enhances surgical instrument sterilization efficiency, particularly for high-turnover instruments in hospitals and ambulatory surgical centers.
      • Features a unique filtration system for steam penetration and sterility maintenance for up to 48 hours.

    Steris PLC Expands Portfolio with Acquisition of Cantel Medical Corporation

    • In June 2021, Steris PLC acquired Cantel Medical Corporation.
      • The acquisition allows Steris to offer a broader range of infection prevention and procedural products and services.
      • Cantel Medical Corporation specializes in offsite sterilization products and services.

    Market Segmentation

    • By Type: Contract Sterilization Services, Sterilization Validation Services.
    • By Service Technology: Ethylene Oxide Sterilization, Gamma Sterilization, Electron Beam Sterilization, Steam Sterilization, No2 Sterilization, Other Service Technologies.
    • By End User: Hospitals, Clinics, Medical Device Companies, Pharmaceutical Companies, Food and Beverage Companies, Academic and Research Institutes, Other End Users.

    Regional Insights

    • North America was the largest region in the offsite sterilization service market in 2023.
    • Continued growth is expected, driven by technological advancements and increased healthcare infrastructure investments.

    The offsite sterilization service market is set for significant growth, driven by the increasing prevalence of HAIs, technological advancements, and strategic acquisitions. As the demand for efficient and effective sterilization solutions continues to rise, the market will play a crucial role in enhancing healthcare safety and operational efficiency.

    Request A Sample Of The Global Offsite Sterilization Service Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=13892&type=smp

  • Growth Trajectory Of The Minimally Invasive Vertebral Compression Fracture Treatment Market 2024-2033

    Growth Trajectory Of The Minimally Invasive Vertebral Compression Fracture Treatment Market 2024-2033

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    Market Growth Overview

    • The minimally invasive vertebral compression fracture treatment market has seen rapid growth.
      • Market size increased from $1.22 billion in 2023 to $1.34 billion in 2024.
      • Achieved a compound annual growth rate (CAGR) of 10.4%.
      • Key drivers: increased incidence of vertebral compression fractures, advancements in surgical devices, rising demand for minimally invasive procedures, aging population, and economic factors.

    Future Market Projections

    • The market is expected to continue its strong growth trajectory.
      • Projected to reach $1.89 billion in 2028 at a CAGR of 8.9%.
      • Growth drivers: growing awareness and education, emerging markets, advancements in imaging technologies, increasing investment in research and development, supportive regulatory frameworks.

    View More On The Minimally Invasive Vertebral Compression Fracture Treatment Market Report 2024 – https://www.thebusinessresearchcompany.com/report/minimally-invasive-vertebral-compression-fracture-treatment-global-market-report

    Major Trends in the Forecast Period

    • Product innovations.
    • Strategic partnerships.
    • Technological advancements.

    Rising Prevalence of Osteoporosis Drives Growth

    • Osteoporosis is a key factor driving market growth.
      • Osteoporosis weakens bones, increasing the risk of fractures and decreasing bone density.
      • Minimally invasive treatments offer advanced, effective solutions for managing fractures.
      • Example: In Australia, osteoporosis contributed to 2,366 deaths and 9,500 hospitalizations in 2021-22.

    Key Market Players

    • Major companies in the market include:
      • Cigna Healthcare
      • Johnson & Johnson
      • Medtronic plc
      • Stryker Corporation
      • Zimmer Biomet
      • Halma Plc
      • Hoag Orthopedic Institute
      • Merit Medical Systems
      • Globus Medical
      • Orthofix Medical Inc.
      • Aesculap Implant Systems LLC
      • Alphatec Holdings Inc.
      • RTI Surgical
      • CareFusion Corporation
      • Lindare Medical Ltd.

    Cutting-Edge Access Retractor Systems

    • Companies are focusing on developing advanced technologies like access retractor systems.
      • These systems facilitate less invasive surgical procedures.
      • Example: In April 2023, Orthofix Medical Inc. launched the Lattus Lateral Access System and Fathom Pedicle-Based Retractor System.
      • Benefits: ease of use, versatility, independent blade retraction strength, enhanced surgical workflow, improved visualization.

    Halma Plc Expands into Minimally Invasive Medical Solutions

    • In October 2022, Halma plc acquired IZI Medical Products for $175.43 million.
      • This acquisition strengthens Halma’s position in minimally invasive diagnosis and treatment.
      • IZI Medical Products specializes in minimally invasive solutions, particularly in interventional spine procedures.

    Market Segmentation

    • By Surgery: Minimally Invasive Spine Surgery, Open Spine Surgery.
    • By Technology: Balloon Kyphoplasty, Vertebroplasty.
    • By End-User: Hospitals, Ambulatory Surgery Centers (ASCs).

    Regional Insights

    • North America was the largest region in the market in 2023.
    • Asia-Pacific is expected to be the fastest-growing region during the forecast period.

    The minimally invasive vertebral compression fracture treatment market is poised for significant growth, driven by the rising prevalence of osteoporosis, advancements in surgical technologies, and strategic industry partnerships. As awareness and adoption of minimally invasive procedures increase, the market will continue to evolve, offering improved patient outcomes and enhanced healthcare efficiency.

    Request A Sample Of The Global Minimally Invasive Vertebral Compression Fracture Treatment Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=13881&type=smp